These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 5941651

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Metabolic acidosis in cyanotic congenital heart disease in infancy.
    Jordan SC.
    Br Heart J; 1969 Nov; 31(6):797. PubMed ID: 5358180
    [No Abstract] [Full Text] [Related]

  • 3. [The use of THAM for prevention of acidosis in terminal states resulting from blood loss].
    Negovskiĭ VA, Trubina IE.
    Ortop Travmatol Protez; 1966 May; 27(5):30-5. PubMed ID: 5993330
    [No Abstract] [Full Text] [Related]

  • 4. The treatment of acidosis in acute lung injury with tris-hydroxymethyl aminomethane (THAM).
    Kallet RH, Jasmer RM, Luce JM, Lin LH, Marks JD.
    Am J Respir Crit Care Med; 2000 Apr; 161(4 Pt 1):1149-53. PubMed ID: 10764304
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [A new buffer substance for combating acidosis: Tham].
    Sarcinelli L, Gennaioli D, Baldieri M.
    Policlinico Prat; 1966 Sep 19; 73(38):1261-8. PubMed ID: 5991039
    [No Abstract] [Full Text] [Related]

  • 7. Proceedings: Metabolic acidosis following regional circulatory arrest: treatment by THAM, hyperventilation and hyperbaric oxygen.
    Benichoux R.
    J Cardiovasc Surg (Torino); 1973 Sep 19; 14(6):573-7. PubMed ID: 4764807
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [The use of THAM (2-amino-2-hydroxymethyl-1,3-propanediol) in corrections of respiratory and metabolic acidosis].
    Aletti L, Minetto E, Maritano M.
    Minerva Anestesiol; 1966 May 19; 32(5):272-81. PubMed ID: 5964312
    [No Abstract] [Full Text] [Related]

  • 14. [THAM (trihydroxymethylaminomethane)--its properties and clinical usefulness in the treatment of systemic acidosis].
    Bielecki K, Oknińska H.
    Pol Tyg Lek; 1968 Sep 05; 23(32):1211-3. PubMed ID: 5687195
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Functional hyposplenia in cyanotic congenital heart disease.
    Pearson HA, Schiebler GL, Spencer RP.
    Pediatrics; 1971 Aug 05; 48(2):277-80. PubMed ID: 5560621
    [No Abstract] [Full Text] [Related]

  • 18. [Administration of THAM to newborn infants born asphyxiated, with the aim of eliminating pathological metabolic acidosis in the blood].
    Manukian BA.
    Vopr Okhr Materin Det; 1969 Jan 05; 14(1):25-30. PubMed ID: 5768715
    [No Abstract] [Full Text] [Related]

  • 19. Hypernatremia in a patient with cyanotic congenital heart disease.
    Capel I, Subirana MT, Rodríguez-Espinosa J, Corcoy R.
    Int J Cardiol; 2008 Jul 21; 127(3):e116-7. PubMed ID: 17764765
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.